You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

non-small cell lung cancer (stage III or IV)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Unresectable Melanoma, Metastatic Melanoma, Stage III NSCLC Trial in Louisville, New York (IOV-4001)

Recruiting
  • Unresectable Melanoma
  • +3 more
  • IOV-4001
  • Louisville, Kentucky
  • +2 more
Nov 21, 2022

Non Small Cell Lung Cancer Trial in Shanghai (CS1001 mAb, CS1001 )

Active, not recruiting
  • Non Small Cell Lung Cancer
  • CS1001 monoclonal antibody
  • CS1001 placebo
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Nov 8, 2022

Recurrent NSCLC, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Buffalo (therapeutic lymphadenectomy (TEMLA) and Stereotactic Body

Completed
  • Recurrent Non-small Cell Lung Cancer
  • +3 more
  • therapeutic lymphadenectomy (TEMLA) and Stereotactic Body radiation therapy (SBRT)
  • quality-of-life assessment
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8 Trial in Rochester (Best Practice,

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Best Practice
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 14, 2023

NSCLC (NSCLC), Stage IV Trial in Switzerland (Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy),

Not yet recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • Stage IV
  • Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy)
  • +2 more
  • Aarau, Switzerland
  • +7 more
Oct 27, 2023

Blood Samples in Patients With Non-small Cell Lung Cancer

Recruiting
  • Stage III Non-Small Cell Lung Cancer AJCC v7
  • +3 more
  • Biospecimen Collection
  • Laboratory Biomarker Analysis
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 18, 2022

Non Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer Trial in United States (BMF-219)

Recruiting
  • Non Small Cell Lung Cancer
  • +16 more
  • Goodyear, Arizona
  • +10 more
Jan 24, 2023

Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Sacramento

Recruiting
  • Advanced Colorectal Carcinoma
  • +15 more
  • Fermented Wheat Germ Extract
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Jul 26, 2023

Anorexia, Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Houston (Anamorelin Hydrochloride, Placebo,

Active, not recruiting
  • Anorexia
  • +8 more
  • Anamorelin Hydrochloride
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Non-Small Cell Cancer AJCC v7

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • New Haven, Connecticut
  • +4 more
Jan 27, 2023

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +24 more
  • 18F-Fluoromisonidazole
  • +4 more
  • La Jolla, California
  • +15 more
Jan 3, 2023

Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Trial in

Recruiting
  • Locally Advanced Lung Non-Small Cell Carcinoma
  • +12 more
  • Computed Tomography
  • Contrast Agent
  • New Brunswick, New Jersey
  • +1 more
Nov 2, 2022

Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Carcinoma Trial in Houston

Active, not recruiting
  • Advanced Colorectal Carcinoma
  • +24 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 20, 2022

Mesothelin Positive, Stage III NSCLC AJCC v7, Stage IIIA NSCLC AJCC v7 Trial in Phoenix, Jacksonville, Rochester (Anetumab

Terminated
Has Results
  • Mesothelin Positive
  • +4 more
  • Anetumab Ravtansine
  • +2 more
  • Phoenix, Arizona
  • +2 more
Jan 5, 2023

Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT

Recruiting
  • Lung Cancer Stage III
  • Lung Cancer Stage IV
    • Brest, France
      Chu Brest
    Aug 16, 2023

    Lung Cancer, NSCLC, Stage III, NSCLC Stage IV Trial in Drammen (sotorasib)

    Recruiting
    • Lung Cancer
    • +6 more
    • Drammen, Viken, Norway
      Vestre Viken Health Trust
    May 30, 2022

    Caregiver, Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial in Houston (Educational Intervention,

    Recruiting
    • Esophageal Carcinoma
    • +16 more
    • Educational Intervention
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 11, 2022

    Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8 Trial in Los Angeles (Atezolizumab

    Recruiting
    • Lung Non-Small Cell Carcinoma
    • +10 more
    • Atezolizumab and Recombinant Human Hyaluronidase
    • Survey Administration
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Jan 31, 2023

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +41 more
    • Ipilimumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 11, 2022

    Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma Trial in Seattle

    Terminated
    Has Results
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +12 more
    • Laboratory Biomarker Analysis
    • ROR1 CAR-specific Autologous T-Lymphocytes
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 11, 2022

    Advanced Lung Non-Small Cell Carcinoma, Locally Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in

    Recruiting
    • Advanced Lung Non-Small Cell Carcinoma
    • +9 more
    • Biopsy
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Aug 2, 2022

    Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial (Nivolumab,

    Withdrawn
    • Lung Non-Small Cell Carcinoma
    • +12 more
    • (no location specified)
    May 24, 2022

    Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8 Trial (drug, procedure,

    Not yet recruiting
    • Advanced Lung Non-Small Cell Carcinoma
    • +3 more
    • (no location specified)
    Oct 21, 2023

    Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III Lung

    Recruiting
    • Advanced Lung Non-Squamous Non-Small Cell Carcinoma
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 29, 2022

    Advanced Head and Neck Squamous Cell Carcinoma, Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma Trial in

    Recruiting
    • Advanced Head and Neck Squamous Cell Carcinoma
    • +14 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Indianapolis, Indiana
    • +4 more
    Aug 19, 2022